Which gene mutation is commonly targeted in non-small cell lung carcinoma with tyrosine kinase inhibitors?
Show answer and explanation
Correct answer: EGFR
EGFR mutations in non-small cell lung carcinoma can be treated with tyrosine kinase inhibitors. Molecular testing identifies patients eligible for targeted therapy.
Keep practicing
More Precision Medicine questions
- Microsatellite instability (MSI) testing is particularly important in:
- Which sequencing approach targets only selected genes of interest?
- PD-L1 expression testing is used to guide therapy in which context?
- A germline BRCA1 mutation primarily increases the risk of:
- Which method is most suitable for detecting copy number variations?
- The concept of actionable mutation refers to: